This website is intended for healthcare professionals. If you are a member of the public, please  visit our public website.



How much iron does Feraccru contain?

Each Feraccru capsule contains 231.5mg of ferric maltol, which is equivalent to 30mg of elemental iron.1,2

Is Feraccru suitable for vegans or vegetarians?

No, Feraccru contains lactose and gelatin of bovine (beef) origin, so is not suitable for vegans or vegetarians.1,3

Is Feraccru sugar-free?

No, Feraccru contains lactose which is a milk sugar.1

Are Feraccru capsules modified/prolonged release?

No, Feraccru capsules are an immediate-release formulation.1

Can you open Feraccru capsules?

Feraccru capsules should not be opened. They should be swallowed whole.1

Can you pour the contents of Feraccru capsules down a feeding/NGT/PEG tube?

Feraccru capsules should not be opened. They should be swallowed whole. We do not have any information on using Feraccru for this mode of administration.1

Can children take Feraccru?

The safety and efficacy of Feraccru in children (17 years & under) has not yet been established and so no data is available.1

Can you use Feraccru to treat IDA not caused by IBD?

Yes, Feraccru is now licensed to treat iron deficiency, with or without anaemia and is no longer restricted to use in patients with IBD.1

How should Feraccru be taken?

Feraccru should be taken whole on an empty stomach (with half a glass of water); do not take with food as this reduces the absorption of iron.1

Can Feraccru be used in patients with Hb <9.5g/dL?

Feraccru should not be used in IBD patients with haemoglobin <9.5g/dL. We have not studied the use of Feraccru in these patients.1
However, our phase 3 CKD study included patients with haemoglobin levels as low as 8g/dL.

Can patients take other vitamin supplements while on Feraccru?

The absorption of oral iron may be reduced by calcium and magnesium. They should be given at least 2 hours apart from Feraccru.1

Is Feraccru suitable for patients that are pregnant or breastfeeding?

We do not have any clinical data in this population. A benefit/risk assessment should be made before prescribing Feraccru.1,4